购物车
0
有库存
sdf 文件
结构编辑
类似物检索
- HIT ID:HIT214320620
- Cas No:2123485-34-5
- 常用名:(±)19(20)-EDP Ethanolamide
- InChI key:HQRHKQCFLLFLJV-MBYQGORISA-N
- 分子式:C24H37NO3
- 分子量:387.564
- 氢键供体数 (HBD):
- 氢键受体数 (HBA):
- LogP:
- (±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). It is produced through direct epoxygenation of docosahexaenoyl ethanolamide by cytochrome P450 (CYP) epoxygenases. (±)19(20)-EDP ethanolamide (25 μM) reduces the viability of 143B metastatic osteosarcoma cells. It decreases the production of IL-6 and increases the production of IL-10 when used at concentrations ranging from 2.5 to 10 μM in BV-2 microglia stimulated by LPS and decreases LPS-induced cytotoxicity when used at concentrations ranging from 5 to 10 μM. It also decreases nitrite production when used at a concentration of 7.5 μM, an effect that can be partially reversed by the CB2 receptor antagonist AM630 and the PPARγ antagonist GW 9662 . (±)19(20)-EDP ethanolamide induces vasodilation of isolated preconstricted bovine coronary arteries (ED50 = 1.9 μM) and reduces tube formation by human microvascular endothelial cells (HMVECs) in a Matrigel assay.
市场产品/服务共显示1个结果
- 供应商TargetMol规格货期35日内发货纯度-¥ 987.001
寻找合适的化合物库
您无法确定哪种化合物库最适合您的项目？或者您需要定制解决方案？Anymole随时为您提供帮助。
电话：400820-0310
合作：info@screeningcompound.com
技术支持：tech@screeningcompound.com
客服：service@screeningcompound.com
查看大图
正在加载 ~